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Informed consent for abdominal aortic aneurysm
repair: Assessing variations in surgeon opinion
through a national survey
Loren Berman, MD, Alan Dardik, MD, PhD, Elizabeth H. Bradley, PhD,
Richard J. Gusberg, MD, and Liana Fraenkel, MD, MPH, New Haven, Conn
Objective: Informed consent discussions for elective abdominal aortic aneurysm (AAA) repair should reflect appropriate
risks of the open or endovascular repair (EVAR), but few guidelines exist describing what surgeons should discuss. This
study examines expert opinion regarding what constitutes informed consent.
Methods: Design. We conducted an anonymous, web-based, national survey of vascular surgeons. Associations between
surgeon characteristics and opinions regarding informed consent were measured using bivariate statistics; multivariable
logistic regression was performed to estimate effects adjusted for covariates. Setting. Academic and private practice
surgeons were surveyed. Subjects. United States members of the International Society for Vascular Surgery membership.
Main Outcome Measure. Surgeons’ self-reported opinions regarding the content of informed consent for AAA repair.
Results: A total of 199 surgeons completed the survey (response rate 51%). More than 90% of respondents reported that
it was essential to discuss mortality risk for both procedures. However, only 60% and 30% of respondents reported that
it was essential to discuss the risk of myocardial infarction and stroke, respectively. Opinions varied by procedure
regarding the risks of impotence (32% vs 62%; EVAR vs open repair), reintervention (78% vs 17%), and rupture during
long-term follow-up (57% vs 17%). Younger and private practice surgeons were more likely to discuss complications
compared with older surgeons and those in academic practice. Surgeons who perform predominantly EVAR were more
likely to quote higher mortality rates for open repair (odds ration [OR]  3.1, 95% confidence interval [CI]  1.4-6.4)
and lower reintervention rates for EVAR (OR  0.3, 95% CI  0.1-0.7) compared with other surgeons.
Conclusions: This is the first study of the practice of informed consent for AAA repair. The only risk that the vast majority
of surgeons agreed should be included in informed consent for AAA repair was mortality. Significant variation exists
regarding whether other complications should be discussed and what complication rates should be quoted. Surgeon
characteristics may influence how risks are presented to patients. Further efforts are needed to develop guidelines to
ensure consistent communication of appropriate risk during informed consent for AAA repair. ( J Vasc Surg 2008;
47:287-95.)Abdominal aortic aneurysm (AAA) is common, affect-
ing 1% of individuals over the age of 551-4 and increasing in
incidence by 2% to 4% per decade thereafter.5,6 Although in
early stages it is usually asymptomatic, the simple presence
of an AAA still poses a significant mortality risk. Indications
for surgical repair vary depending on the individual pa-
tient’s preferences, both in terms of the decision to repair
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doi:10.1016/j.jvs.2007.10.050the aneurysm at all and whether to use an open or endo-
vascular technique. In general, AAA repair is indicated for
aneurysms of at least 5.5 cm.7,8
Few studies have directly compared the long-term out-
comes of open and endovascular repair. Open repair is
remarkably successful for most patients, with perioperative
mortality ranging from 1% to 5% at centers of excellence9
and quality of life measures returning to baseline by 6
months after the operation for most patients.10 However,
up to 28% of patients may experience complications related
to the invasiveness of the operation.11 Endovascular repair
(EVAR) has recently emerged as an alternative to open
repair. Evidence demonstrates decreased short-term mor-
bidity and mortality with this procedure compared with
open repair.12-14 Long-term outcomes associated with this
newer technique are uncertain, however, and annual rein-
tervention rates as high as 10% have been reported.15
Reintervention can often be managed with endovascular
techniques, but open revision may be required in up to 1%
to 2% of patients per year.16 Observational studies evaluat-
ing quality of life and quality-adjusted life expectancy have
revealed no significant differences between EVAR and open
repair.10,17,18
The decision to undergo elective AAA repair, a prophy-
lactic intervention in generally elderly and asymptomatic
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EVAR, is an extremely complex one that should rely on
clear, consistent communication of the risks and benefits
that are associated with each option. Therefore, the objec-
tive of this study was to define national surgeon opinion
regarding the content of informed consent discussions for
both EVAR and open AAA repair.
METHODS
Study design and sample
We conducted a cross-sectional survey of the US mem-
bers of the International Society for Vascular Surgery
(ISVS) in 2007. This society was formed in 2003 in order
to promote vascular surgery as a distinct medical specialty
worldwide. The membership of the society (approximately
400 US members) includes vascular surgeons from aca-
demic and private practice settings. We developed a web-
based survey (see Appendix, online only) in a collaborative
effort between several vascular surgeons and an expert in
survey design (EHB). The survey was pilot-tested on five
vascular surgeons, revised, and then distributed by e-mail
to all US members. All research procedures were approved
by the Yale University School of Medicine Human Investi-
gation Committee.
Survey measures
The primary outcomes of interest were surgeons’ per-
spectives on: (1) the importance of discussing various com-
plications, and (2) the rates that should be quoted for each
complication.We asked respondents to rate the importance
of discussing each complication described in the survey
using a 1-5 scale where 1 indicated “essential” and 5
indicated “not needed.” This task was repeated for patients
with varying hypothetical comorbidity profiles, and sur-
geons were given the opportunity to list additional compli-
cations at the end of the survey. We also asked respondents
which complication rates should be quoted to patients with
and without comorbidities, using a scale of 1%, 1%,
2%-3%, 4%-5%, or other (open-ended).
We collected data regarding practice setting, gender,
age group, number of years in practice, and number of
EVAR and open repairs performed per year. We also asked
respondents to describe their current practice with regard
to obtaining informed consent from patients who are can-
didates for both EVAR and open surgery. For the purpose
of the analysis, the following surgeon characteristics were
included: surgeon age (50 vs 50), practice setting (ac-
ademic vs private practice), and reported case majority
(50% EVAR vs 50% EVAR). To examine whether atti-
tudes toward the legal consequences of informed consent
may be shaping surgeons’ opinions, we compared the re-
sponses of surgeons practicing in states that are currently
experiencing a malpractice crisis as determined by the
AMA19 (Wash, Ore, Nev, Wyo, Mo, Ill, Ky, Tenn, NC,
Ohio, Fla, Pa, NY, NJ, Conn, RI, Mass) to those practicing
in non-crisis states.Data analysis
We performed standard frequency analyses to describe
the study sample and responses to survey questions. We
classified surgeons’ opinions related to the necessity of
including specific complications as part of the informed
consent process into one of three categories: “Should be
included,” “Not necessary to include,” and “Uncertain.”
This classification was based on the most frequently re-
ported response for each complication. If “essential” was
the most frequently reported response, then that complica-
tion was classified as “should be included,” and if “not
needed” was most frequently reported, then that compli-
cation was classified as “not necessary to include.” All other
complications were categorized as “uncertain,” as there was
lack of agreement among surgeons as to whether or not
they should be discussed during informed consent.
In order to examine associations between surgeon
characteristics and survey responses, we performed bivari-
ate analyses, using 2 and Fisher’s exact test as appropriate.
For the analyses of survey responses related to the impor-
tance of discussing specific complications, responses were
dichotomized as “essential” vs “non-essential,” with 1 la-
beled “essential” and 2 through 5 labeled “non-essential.”
Survey responses regarding complication rates to be quoted
were analyzed as a four-level outcome variable (1%, 1%,
2%-3%, 4%-5%). To adjust for covariates, we performed
multivariable logistic regression on outcome variables for
which a significant association (P  .05) had been identi-
fied during bivariate analysis. All statistical analyses were
performed using SAS, 9.1 (SAS Institute Inc., Cary, NC).
RESULTS
We received responses from 199 of the 388 surgeons
who were contacted (response rate 51%).
Description of sample (Table I)
The majority of respondents were male (83%), which is
reflective of a strong male majority in the population that
was surveyed (97%). Most surgeons were between the ages
of 40 and 60 (58%) and had been in practice for at least 11
years (66%). With regard to practice setting, 48% reported
that they were in private practice, and 37% were academic
surgeons. A total of 32% of surgeons reported that they
perform mostly open repairs (median 15 open and 10
EVAR per year), 47% reported that they perform mostly
EVAR (median 25 EVAR and 10 open per year), and 11%
stated that they perform both procedures with equal fre-
quency. Close to half of the sample (47%) lives in malprac-
tice crisis states, and 38% live in non-crisis states. Ap-
proaches to the preoperative discussion of intervention
options with a patient who is a candidate for both open
repair and EVAR can be summarized as follows: 56% would
discuss both options and recommend one or the other, 31%
would discuss both and ask which one the patient would
prefer, and less than 1%would recommend one or the other
without discussing both.
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including specific complications (Table II)
The percent of surgeons responding in each category
(from 1  essential to 5  not needed) for each of the
complications included in the survey are listed in Table II.
Additional risks to be included during the informed consent
process suggested by respondents are listed in Table III.
Complications related to open repair. For open re-
pair, respondents felt that mortality, myocardial infarction,
renal failure, impotence, and prolonged mechanical venti-
lation should be discussed during informed consent, and
radiation, contrast exposure, and postoperative rupture
were not necessary to include. There was no agreement
among respondents as to whether to discuss stroke, perma-
nent disability, or reintervention.
As expected, a history of specific risk factors increased
surgeons’ perceived importance of disclosing the related
complication. For example, a history of previous stroke
increased the percent of surgeons classifying stroke as an
essential complication to discuss during informed consent
Table I. Surgeon characteristics
Characteristic Number (%)
Gender
Male 165 (83%)
Female 7 (4%)
Missing 27 (13%)
Practice setting
Academic 73 (37%)
Private 95 (48%)
Missing 31 (15%)
Age group
40 y 22 (11%)
40-50 y 52 (26%)
51-60 y 63 (32%)
61-70 y 27 (14%)
70 y 10 (5%)
Missing 25 (12%)
Years in practice
1-5 27 (13%)
6-10 17 (9%)
11-20 49 (25%)
21-30 48 (24%)
30 33 (17%)
Missing 25 (12%)
Majority surgery performed
Open 63 (32%)
EVAR 93 (47%)
Equal open and EVAR 22 (11%)
Missing 21 (10%)
Malpractice climate
Crisis state 94 (47%)
Non-crisis state 75 (38%)
Missing 30 (15%)
Approach when patients are candidates for
both procedures
Discuss both, ask which patient prefers 62 (31%)
Discuss both, recommend one 111 (56%)
Recommend one without discussing both 1 (1%)
Missing 25 (12%)
EVAR, Endovascular repair.from 26% to 43%.Complications related to EVAR. As with open re-
pair, surgeons reported that mortality, myocardial infarc-
tion, renal failure, and impotence should be discussed;
permanent disability was not necessary to discuss, and
whether to discuss stroke was uncertain.
In contrast to open repair, however, surgeons reported
that risks related to postoperative surveillance (radiation
and contrast exposure), postoperative rupture, and reinter-
vention should be included when informing patients about
EVAR. In addition, although surgeons reported that the
risk of prolonged mechanical ventilation should be in-
cluded in the informed consent process for open repair,
there was no agreement regarding disclosure of this risk for
EVAR.
As with open repair, a history of specific risk factors
increased surgeons’ perceived importance of disclosing the
related complication. For example, for patients with chronic
obstructive pulmonary disease, 43% of surgeons felt that pro-
longed mechanical ventilation should be included, compared
with only 17% for the average patient.
Surgeons’ opinions on complication rates
Surgeons’ opinions regarding complication rates var-
ied, however, most responses were within the range of
those reported in the literature (see Table IV). As noted in
Table IV, there are few published reports on how compli-
cation rates vary according to patient comorbidity status. In
general, survey respondents quoted higher rates of mortal-
ity, myocardial infarction, and impotence, similar rates of
renal failure, and lower rates of reintervention and postop-
erative rupture after open repair compared with EVAR.
Associations between surgeon characteristics and
opinions (Tables V, VI, and VII)
Surgeon experience, age, and practice setting were each
related to differences in opinions regarding the necessity of
including specific complications in the informed consent
process. Those who perform primarily EVAR were less
likely to state that renal failure and mechanical ventilation
should be discussed during informed consent for open
repair or EVAR compared with those who perform primar-
ily open or equal numbers of EVAR and open repairs.
Younger surgeons were more likely to state that the risk of
myocardial infarction for both EVAR and open repair, and
disability for open repair, be discussed. Surgeons in private
practice reported that a greater number of complications
should be discussed (renal failure for open and EVAR, and
myocardial infarction and prolonged mechanical ventilation
for open) compared with academic surgeons (Table V).
There were also a number of significant associations
between surgeon characteristics and survey responses re-
garding which complication rates to quote. Surgeons who
perform mostly EVAR were more likely to quote higher
mortality rates after open repair and lower reintervention
rates after EVAR compared with surgeons who perform
equal numbers of both procedures, or more open repairs.
Younger surgeons were more likely to quote higher mor-
tality rates after open repair and higher myocardial infarc-
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surgeons. Compared with private practice surgeons, aca-
demic surgeons were more likely to quote higher myocar-
dial infarction rates after open repair and lower rupture
rates after EVAR (Table VI).
There were no significant differences in opinions re-
garding what should be discussed between surgeons in
malpractice crisis states and those in non-crisis states. For
example, 53% of crisis state surgeons considered renal fail-
ure essential to discuss for open repair informed consent,
compared with 54% of non-crisis state surgeons (P  .92).
Many associations between surgeon characteristics and
opinions regarding informed consent persisted in multivari-
able analysis after controlling for practice setting, most fre-
quently performed surgery, and surgeon age (Table VII).
DISCUSSION
This is the first study describing surgeon opinion
Table II. Percentage of surgeons responding in each catego
Risk
Open
1 Essential 2 3 4
Mortality 97% 2% 1% 0%
Myocardial infarction 67% 21% 6% 3%
Stroke 26% 14% 27% 12%
Renal failure 48% 22% 12% 7%
Impotence 62% 17% 6% 3%
Mechanical ventilation* 34% 25% 15% 9%
Permanent disability 19% 20% 20% 13%
Contrast exposure 12% 4% 16% 16%
Radiation exposure 4% 6% 12% 13%
Reintervention 17% 19% 22% 23%
Postoperative rupture 17% 5% 11% 23%
EVAR, Endovascular repair.
*Refers to prolonged mechanical ventilation for 24 hours after surgery.
Table III. Open-ended survey responses
Complication
Number of respondents listing
complication
Infection (graft/wound) 19
Paralysis/paraplegia 15
Limb loss/ischemia/claudication 15
Bowel ischemia/possible ostomy 12
Hernia 7
Embolization 7
Ileus/obstruction 6
DVT/PE 6
EVAR conversion to open 6
Need for transfusion 5
Retrograde ejaculation 4
Bleeding 4
Graft thrombosis 4
Lymph leak 3
Pneumonia 2
Ureteral injury 2
Aorto-enteric fistula 2
EVAR, Endovascular repair; DVT/PE, deep vein thrombosis; PE, pul-
monary embolism.regarding the content of what should be included duringthe process of informed consent for AAA repair. The
survey responses are a valuable representation of collec-
tive surgeon opinion, as we were able to achieve a high
response rate. The results of this survey improve our
understanding of surgeon opinion related to the in-
formed consent process for AAA repair. Although open
AAA repair has been performed safely for over 50 years,
and endovascular methods have been maturing for over
10 years, most reports regarding repair of aneurysms
focus on a limited number of short-term outcome mea-
sures such as mortality and major morbidity. Other
outcomes, including those which may be particularly
important to patients such as stroke and long-term dis-
ability, have not been well studied.
Consequently, it is not surprising that there are no
established guidelines to advise physicians on how to dis-
cuss informed consent for AAA repair. Our results indicate
that the risks of mortality, myocardial infarction, renal
failure, and impotence should be discussed during in-
formed consent for both EVAR and open repair. For open
repair, the risk of prolonged mechanical ventilation should
also be included, whereas risks related to long-term en-
dograft surveillance (contrast and radiation exposure) and
risks of reintervention and postoperative rupture should be
included for EVAR only.
Although we have summarized survey responses in
order to create a framework for the informed consent
discussion, it is important to recognize that our results
reflect substantial variability in opinion. For example, 48%
of surgeons answered that it was “essential” to discuss risk
of renal failure after open repair, and because this was the
most frequent response, we classified this risk as one that
should be included in the informed consent process even
though 52% of the respondents had a different opinion. In
other cases, the variability was even more striking. For
example, 19% of surgeons reported that it was essential to
discuss risk of permanent disability after open repair, 13%
reported that it was not needed, and 43% were less certain.
Similar variability was seen in responses regarding the im-
r importance of discussing risks during informed consent
EVAR
ot needed 1 Essential 2 3 4 5 Not needed
0% 94% 4% 2% 0% 0%
2% 58% 21% 11% 5% 3%
13% 28% 14% 23% 13% 15%
2% 53% 18% 12% 6% 3%
2% 32% 14% 10% 13% 19%
5% 17% 12% 21% 20% 17%
13% 12% 12% 20% 18% 23%
39% 69% 9% 7% 2% 0%
51% 38% 19% 13% 9% 8%
6% 78% 5% 2% 0% 0%
28% 57% 11% 9% 6% 1%ry fo
5 Nportance of discussing reintervention after open repair,
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after either procedure. With regard to which complication
rates should be quoted, the survey results again demon-
strated variability, but most responses were in the range of
literature-based values.
The variability seen in survey responses is in part ex-
plained by surgeon characteristics. For example, surgeons
whose caseload is greater than 50%EVARwere significantly
more likely to quote higher mortality rates with open
surgery, and lower reintervention rates with EVAR, com-
pared with surgeons whose caseload is at least 50% open.
This suggests that surgeons who primarily perform EVAR
would be more likely to present patients with a risk profile
which favors the endovascular option.
We also found that younger surgeons and surgeons in
private practice believe that a greater number of risks are
essential to discuss compared with their older and academic
counterparts. For example, younger surgeons were more
than three times as likely to rate discussion of myocardial
infarction as essential for EVAR and open informed con-
sent compared with older surgeons, and private practice
surgeons were more than three times as likely to rate
myocardial infarction or renal failure as essential for open
informed consent compared with academic surgeons. It is
possible that younger, less experienced surgeons would be
more conservative about risk estimates, and more inclusive
of various risks when discussing informed consent, com-
pared with older surgeons. As for the differences between
private and academic surgeons, there could be variation
between these groups with regard to concerns about liabil-
ity, perhaps related to whether or not a practice is self-
insured. It is also likely that there are differences in case mix
between groups; that is, if a group of surgeons has a practice
comprised of high-comorbidity patients, they may be less
likely to consider certain risks essential to discuss during
informed consent for an “average” patient. We did not find
Table IV. Complication rates most frequently quoted in s
Complication Surv
Mortality 2 to
Myocardial infarction 2 to
Myocardial infarction for patient with coronary
artery disease
5
Myocardial infarction for patient with risk
factors for coronary artery disease
2 to
Stroke 1
Stroke for patient with stroke history 1
Renal failure 1
Renal failure for patient with renal insufficiency 4 to
Renal failure for patient with diabetes 2 to
Impotence 4 to
Reintervention rate (percent per year) 1
Rupture rate (percent per year) 1
NA, Not available.
aLiterature refers to “cardiac complications” including myocardial infarctio
bLiterature refers to any postop hemodialysis (not necessarily permanent).any significant differences in the opinions of surgeons prac-ticing in malpractice crisis states versus non-crisis states.
However, it is possible that our measure was not sensitive
enough to capture the effect of attitudes towards legal
consequences of inadequate informed consent on sur-
geons’ opinions.
Another important potential factor influencing sur-
geon opinion is surgeon experience. Surgeons are likely to
adapt the content of the informed consent process to
include outcomes relevant to their own practice and quote
complication rates that are reflective of their own experi-
ence or the experience of the center in which they practice.
Therefore, we would expect to see some variability in
opinions related to complication rates due to the range of
surgeon experience and/or expertise.
The variability noted in this study is consistent with
other reports that have examined the process of informed
consent for other procedures.20-24 It is well-documented in
the cardiac surgery literature that there is a great deal of
variation in what surgeons tell patients about a particular
operation during the informed consent encounter, and
perhaps even more so in what patients take away from this
encounter. For example, Vohra et al administered a ques-
tionnaire to patients after they underwent informed con-
sent for cardiac surgery and found that although patients
were well-informed about the type of operation they were
having and the reason for surgery, there was inconsistent
communication of information about risks of and alterna-
tives to the intervention.24
Inconsistent communication and comprehension dur-
ing informed consent can have legal consequences. Al-
though only about 2% of paid malpractice claims are known
to be attributable to informed consent grounds, informed
consent features prominently in malpractice litigation as a
component of other claims that involve medical negligence
or breach of contract.25 The legal definition of informed
consent includes discussion of the risks, benefits, and alter-
y compared with literature-based values
n repair rates EVAR rates
Literature Survey Literature
0 to 16 1 0.6 to 6
5 to 21a 1 1 to 5a
NA 2 to 3 NA
NA 1 to 3 NA
0 to 3 1 0.4 to 2
NA 1 NA
0.6 to 2.2b 1 0 to 1.2b
NA 4 to 5 NA
NA 2 to 3 NA
NA 1 NA
0.3 to 4.6 4 to 5 2 to 15
NA 1 1urve
Ope
ey
3
3
3
5
3
5
n.natives to an intervention. This is a broad definition, and
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explanation of full disclosure. The majority of states follow
a physician-based disclosure rule, that is, what is considered
essential to disclose is a matter of medical professional
judgment that should be resolved by reference to what
other practitioners would commonly disclose in a similar
situation. There are a significant number of states, however,
that follow a patient-based, or “materiality,” standard,
where the scope of the physician’s communication is deter-
mined by what the patient would consider material to the
decision.26
This legal context suggests that in determining what
content should be included in the informed consent pro-
cess, the patient’s perspective must be considered. This is
especially important because, as suggested by other stud-
ies,27-29 there may be differences between patient and
surgeon values. Surgeons may be more likely to discuss
Table V. Association of surgeon characteristics with opini
Surgeons who perform 
% ratin
Complication 50% EVAR
Renal failure
Open 46%
EVAR 50%
Mechanical ventilation
Open 33%
EVAR 14%
Surgeons 50 years ol
% ratin
Complication Age 50
Myocardial infarction
Open 81%
EVAR 72%
Impotence
Open 63%
EVAR 30%
Disability
Open 32%
EVAR 18%
Surgeons in acade
% ratin
Complication Academic
Myocardial infarction
Open 59%
EVAR 56%
Renal failure
Open 40%
EVAR 43%
Mechanical ventilation
Open 28%
EVAR 17%
EVAR, Endovascular repair.complications which are easier to study (usually 30-dayoutcomes), simply because the data are more readily avail-
able. This phenomenon could explain some of the most
frequently reported open-ended responses (for example,
wound infection), as these outcomes are often reported in
the literature but are not necessarily likely to factor into
preoperative decision-making from the patient perspective.
In contrast, outcomes such as permanent disability, which
are clearly important to patients, are more difficult to
quantify and track prospectively and, therefore, may be less
likely to be discussed.
Analysis of the complication rate responses revealed
that, in general, surgeons quote rates that are consistent
with those reported in the literature. However, published
data related to complication rates are limited (Table IV).
There are no standard definitions for many important post-
operative outcomes, and few studies stratify outcomes by
patient risk factor profiles or provide data on long-term
n what is essential to discuss
EVAR vs 50% EVAR
plication as “essential”
50% EVAR P value
70% .007
69% .03
50% .04
26% .09
rgeons 50 years old
plication as “essential”
Age 50 P value
58% .001
50% .003
76% .07
42% .1
15% .009
12% .2
s private practice
plication as “essential”
Private P value
74% .04
60% .7
62% .005
66% .003
49% .006
22% .4ons o
50%
g com
d vs su
g com
mic v
g comfunctional status and quality of life outcomes.
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inherent bias that survey respondents are likely to have a
particular interest in the informed consent process com-
pared with non-responders, so their opinions may not be
generalizeable to the larger population of surgeons. Sec-
ond, the degree of variability in responses makes it difficult
to draw conclusions as to whether a given complication
should or shouldn’t be discussed during informed consent.
Third, in this survey, we did not assess the patient perspec-
tive on what should be discussed during informed consent.
Finally, it is not agreed upon as to whether surgeons should
use their own or generalized data when obtaining informed
Table VI. Association of surgeon characteristics with repo
Surgeons who perform 
Rates to quote 50% EV
Mortality after open
1% 2%
1% 1%
2%-3% 47%
4%-5% 49%
Reintervention after EVAR
1% 3%
1% 13%
2%-3% 30%
4%-5% 54%
Surgeons 50 years ol
Rates to quote Age 
Mortality after EVAR
1% 26%
1% 33%
2%-3% 41%
4%-5% 0%
Myocardial infarction after open repair
1% 13%
1% 23%
2%-3% 44%
4%-5% 21%
Myocardial infarction after EVAR
1% 34%
1% 39%
2%-3% 25%
4%-5% 1%
Surgeons in acade
Rates to quote Acad
Myocardial infarction after open repair
1% 14
1% 20
2%-3% 56
4%-5% 10
Rupture after EVAR
1% 45
1% 45
2%-3% 7
4%-5% 3
EVAR, Endovascular repair.consent.30 Conveying surgeon-specific information is notalways possible, which is why it is necessary to establish
guidelines that would be tailored to individual patients
based on their own risk factors as opposed to individual
surgeon biases.
CONCLUSION
Ensuring that patients are informed of the risks and
benefits associated with EVAR and/or open repair is an
important responsibility of the treating surgeon.9 This is a
particularly difficult task when considering AAA repair be-
cause of the uncertainty related to outcomes and the com-
plexity of having to choose between two procedures with
complication rates
EVAR vs 50% EVAR
50% EVAR P value (trend)
.003
0%
12%
59%
29%
.02
0%
10%
12%
78%
rgeons 50 years old
Age 50 P value (trend)
.02
14%
49%
32%
5%
.05
21%
28%
44%
7%
.04
55%
26%
19%
1%
s private practice
Private P value (trend)
.05
19%
32%
34%
16%
.003
40%
33%
28%
0%rted
50%
AR
d vs su
50
mic v
emic
%
%
%
%
%
%
%
%distinct risk profiles. Whether or not to undertake a pro-
a give
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particularly difficult decision for the elderly, who are at the
highest risk for postoperative morbidity and yet have the
least potential to experience long-term survival benefits.
The variability in surgeons’ opinions demonstrates the
need for further studies to ascertain reliable data on out-
comes that may be difficult to measure, but are particularly
relevant to patients. Standardized definitions of complica-
tions and measurement of complication rates in subgroups
stratified by risk factors are essential in order to facilitate
communication of tailored information. Informed consent,
as currently practiced, appears to be a flawed process.
Further efforts are needed to establish informed consent
guidelines, which could be accomplished by formation of a
panel comprised not only of vascular surgeons but also
patients and legal experts. Dissemination of such guidelines
would facilitate consistent communication of risk to pa-
tients in an unbiased manner, and improve the quality of
informed consent.
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Surgeon Survey
In order to improve patients’ understanding of infrarenal AAA and how it is treated, we are designing an interactive
educational tool for patients who are candidates for open or endovascular AAA repair.
This tool will explain the diagnosis as well as discuss the risks and benefits associated with intervention.
In determining which information to include, we would like to consider input from experts in the field; thus, we are
seeking your opinion. Filling out the questionnaire should take approximately 5–10 minutes. There are 20 questions.
Please assume for each question regarding open AAA repair that you have chosen the approach (i.e. retro-peritoneal vs.
trans-peritoneal) which would be the least risky for a given patient. Responses to this survey will be kept confidential.
1. How important is it to include discussion of mortality risk?
For EVAR: For open AAA repair:
e 1 e 2 e 3 e 4 e 5 e 1 e 2 e 3 e 4 e 5
essential not needed essential not needed
What mortality rate should be quoted?
For EVAR: For open AAA repair:
e 1% e 1% e 2-3% e 4-5% e Other: e 1% e 1% e 2-3% e 4-5% e Other:
All of the following questions use the same response scales as described above and are not relisted.
2. How important is it to include discussion of myocardial infarction (MI) risk?
For the average patient:
For patient with known history of coronary artery disease (CAD):
For patient without CAD but with known risk factors (i.e. smoking, diabetes, hypertension, hyperlipidemia):
What MI rate should be quoted for the average patient?
What MI rate should be quoted for a patient with known history of CAD?
What MI rate should be quoted for patient without CAD but with known risk factors?
3. How important is it to include discussion of stroke risk?
For the average patient:
For a patient with known history of stroke:
What stroke rate should be quoted for the average patient?
What stroke rate should be quoted for a patient with history of previous stroke?
4. How important is it to include discussion of risk of renal failure? This question refers to permanent, dialysis-requiring
renal failure.
For the average patient:
For a patient with pre-operatively compromised renal function:
For a patient with diabetes:
What renal failure rate should be quoted for the average patient?
What renal failure rate should be quoted for a patient with pre-operatively compromised renal function?
What renal failure rate should be quoted for a patient with diabetes?
5. How important is it to include discussion of risk of impotence?
What impotence rate should be quoted?
6. How important is it to include discussion of risk of need for prolonged mechanical ventilation (beyond the first 24 hours
after surgery)?
For average patient:
For patient with COPD:
7. How important is it to include discussion of risk of long-term disability (e.g., disposition to permanent extended care
facility where the patient was living at home pre-op)?
For the average patient:
For someone whose functional status is mildly compromised preoperatively (e.g., lives at home but is somewhat
dependent on spouse for help with activities of daily living):
8. How important is it to include discussion of post-operative surveillance practice? In discussing post-operative surveil-
lance for EVAR, how important is it to include the following?
Risk of contrast exposure:
Risk of radiation exposure:
9. How important is it to include discussion of the likelihood of need for re-intervention after the operation?
Which rate should be quoted?
10. How important is it to include discussion of risk of rupture after repair?
Which rate should be quoted?
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Which of the following possible outcomes should be discussed? Please rate all three.
Risk of rupture if no surgery is performed?
Likelihood of death from rupture if no surgery is performed?
Nature of death from a ruptured aneurysm?
Other:
12. Are there any other issues that should be addressed in an educational tool that we have not asked about in this
questionnaire? If so, please list.
13. If a patient is a candidate for both EVAR and open AAA repair, I generally:
e Discuss both options and ask which one the patient would prefer.
e Discuss both options and recommend one or the other.
e Recommend one or the other without discussing both options.
e Other:
14. Which of the following best describes your primary practice setting?
e Academic e Private practice e Other:
15. Do you practice in a VA hospital?
e Yes e No
16. What is your gender?
e Female eMale
17. What is your age group?
e 40
e 40-50
e 51-60
e 61-70
e 70
18. For how many years have you been practicing vascular surgery?
e 1-5
e 6-10
e 11-20
e 21-30
e 30
19. In which state is your practice located? (States to be listed on drop down menu)
20. Please estimate the number of AAA repairs you do per year:
EVAR:________
Open:________
